4,995
edits
Obesity: Difference between revisions
From W8MD weight loss and sleep centers
no edit summary
No edit summary |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 29: | Line 29: | ||
* Environmental factors that encourage obesity, such as lack of access to healthy foods and physical activity opportunities | * Environmental factors that encourage obesity, such as lack of access to healthy foods and physical activity opportunities | ||
* Genetic and family history factors that influence weight | * Genetic and family history factors that influence weight | ||
* '''[[Stop blaming the victim for obesity]]''' | |||
<youtube>http://www.youtube.com/v/U3oI104STzs</youtube> | |||
=Part 2: Understanding Weight Loss= | =Part 2: Understanding Weight Loss= | ||
| Line 59: | Line 61: | ||
* Hysterectomy for weight loss | * Hysterectomy for weight loss | ||
==Chapter 9: [[Supplements and | ==Chapter 9: [[Weight loss supplements|Weight Loss Supplements]] and [[Meal replacements]]== | ||
* Overview of [[weight loss supplements]] | * Overview of [[weight loss supplements]] | ||
* Effectiveness and risks of weight loss medications and | * Effectiveness and risks of weight loss supplements | ||
==Chapter 10: Prescription [[weight loss medications]]== | |||
For people who struggle with obesity, medication can be a useful tool in their weight loss journey. However, not all medications are created equal. Some can be effective, while others may have dangerous side effects. In this article, we will discuss the different types of anti-obesity medications, their current FDA status, and their efficacy. | |||
* Prescription [[weight loss medications]], including [[Wegovy]] / [[Ozempic]], [[Mounjaro]], [[Liraglutide]] (brand names:[[Saxenda]] / [[Victoza]]), [[Contrave]], [[Plenity]], [[Phentermine/topiramate]], [[Phentermine]], [[Alli]], [[Phentermine]], and [[Metformin]] | * Prescription [[weight loss medications]], including [[Wegovy]] / [[Ozempic]], [[Mounjaro]], [[Liraglutide]] (brand names:[[Saxenda]] / [[Victoza]]), [[Contrave]], [[Plenity]], [[Phentermine/topiramate]], [[Phentermine]], [[Alli]], [[Phentermine]], and [[Metformin]] | ||
* [[Weigh loss injections]] - [[Glucagon-like peptide-1 (GLP-1)]] are peptide incretin hormones involved in blood sugar control. [[Semaglutide]], a GLP-1 analogue, administered once weekly, is more effective than [[exenatide]]. [[Semaglutide]] ([[Ozempic]], [[Wegovy]]) and [[tirzepatide]] ([[Mounjaro]]) are the most promising candidates for weight management in the anti-obesity market. In 2021, one review concluded that "Currently, gut peptide analogues such as semaglutide [...] and [...] tirzepatide are the furthest advanced in clinical development." A further review in 2022 found that these two peptides are "the most promising candidates for the upcoming battle in the anti-obesity market." [[Semaglutide]] has been approved for medical use in the US and the European Union for weight management in adults, sold under the brand name [[Wegovy]]. On the other hand, [[tirzepatide]] has been approved under the name [[Mounjaro]] for type-2 diabetes and is being studied, and fast tracked for [[weight loss]]. | |||
=Part 4: Health Benefits of Weight Loss= | =Part 4: Health Benefits of Weight Loss= | ||
| Line 93: | Line 99: | ||
==Miscellaneous Topics== | ==Miscellaneous Topics== | ||
* [[Obesity: causes and effects]] | * [[Obesity: causes and effects]] | ||
* [[Insulin resistance]] | * [[Insulin resistance]] | ||
| Line 105: | Line 104: | ||
* [[Spot reduction]] | * [[Spot reduction]] | ||
* [[Caloric deficit]] | * [[Caloric deficit]] | ||
* [[Set point theory]] | * [[Set point theory]] | ||
* [[Vegan weight loss]] | * [[Vegan weight loss]] | ||
* [[Hallelujah Diet]] | * [[Hallelujah Diet]] | ||
* [[Eat to Live]] | * [[Eat to Live]] | ||
* [[Serving size]] | * [[Serving size]] | ||
* [[Diet rewards]] | * [[Diet rewards]] | ||
* [[Slimming club]] | * [[Slimming club]] | ||
* [[WholyFit]] | * [[WholyFit]] | ||
==Frequently asked questions== | ==Frequently asked questions== | ||
